Delivery Order #15BFTD27F00000028

Medication Delivery Contract for MAT Therapy at FCI Fort Dix

This award is a delivery order contract under the existing Pharmaceutical Prime Vendor Contract (PPV) indefinite delivery vehicle, specifically for providing Medication Assisted Treatment (MAT) therapy medications to inmates at the Federal Correctional Institution (FCI), Fort Dix. The contract recipient, McKesson Corporation, a leading pharmaceutical distributor and primary contractor under the broader PPV program with the Department of Veterans Affairs, is responsible for the procurement and delivery of these essential medications. This contract is significant because it supports inmate health and rehabilitation by ensuring access to critical therapy medications, enhancing correctional care and public health outcomes. The scope of work involves the timely delivery of MAT therapy medications to the inmate population housed at FCI Fort Dix, as detailed in this particular delivery order. Awarded competitively through the established PPV contract vehicle, this agreement leverages McKesson’s extensive pharmaceutical supply infrastructure. The contract has a multi-year timeline with the current performance period spanning one year, commencing in early October 2026 and concluding in late September 2027. It builds upon McKesson’s prior performance and commitments under the overarching PPV contract awarded originally in 2020, which supports a vast pharmaceutical supply chain for government healthcare programs.

Description

CONTRACTOR TO PROVIDE MEDICATION ASSISTED TREATMENT (MAT) THERAPY MEDICATIONS FOR INMATE POPULATION HOUSED AT FCI, FORT DIX.

View original record